0001104659-24-033164.txt : 20240311 0001104659-24-033164.hdr.sgml : 20240311 20240311214013 ACCESSION NUMBER: 0001104659-24-033164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trizzino John CENTRAL INDEX KEY: 0001468534 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 24740058 MAIL ADDRESS: STREET 1: 9920 BELWARD CAMPUS DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 QUINCE ORCHARD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 700 QUINCE ORCHARD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 tm248549-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-07 0 0001000694 NOVAVAX INC NVAX 0001468534 Trizzino John C/O NOVAVAX, INC. 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 0 1 0 0 EVP, CCO and CBO 0 Common Stock 2024-03-07 4 M 0 28890 A 39545 D Common Stock 2024-03-07 4 F 0 13955 5.61 D 25590 D Restricted Stock Units 2024-03-07 4 M 0 28890 0.00 D Common Stock 57780 0 D Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 7, 2023, the Grant Date, in each case subject to continued employment through such vesting date. /s/ Mark J. Casey, Attorney-in-Fact 2024-03-11